(19)
(11) EP 2 856 157 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.04.2017 Bulletin 2017/17

(45) Mention of the grant of the patent:
28.12.2016 Bulletin 2016/52

(21) Application number: 13725646.7

(22) Date of filing: 24.05.2013
(51) International Patent Classification (IPC): 
G01N 33/53(2006.01)
(86) International application number:
PCT/EP2013/060813
(87) International publication number:
WO 2013/178559 (05.12.2013 Gazette 2013/49)

(54)

METHOD FOR THE DETECTION OF GLYCANS USING POLYPEPTIDES COMPRISING THE CD301 CARBOHYDRATE RECOGNITION DOMAIN

VERFAHREN ZUM NACHWEIS VON GLYCANEN UNTER VERWENDUNG VON POLYPEPTIDEN UMFASSEND DEN CD301 KOHLENHYDRAT-ERKENNUNGSDOMÄN

PROCÉDÉ DE DÉTECTION DE GLYCANES UTILISANT DES POLYPEPTIDES COMPRENANT LE DOMAINE DE RECONNAISSANCE D'HYDRATES DE CARBONE DE CD301

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 28.05.2012 EP 12004109

(43) Date of publication of application:
08.04.2015 Bulletin 2015/15

(73) Proprietors:
  • Wagener, Christoph
    22763 Hamburg (DE)
  • Nollau, Peter
    20146 Hamburg (DE)
  • Niendorf, Axel
    22767 Hamburg (DE)

(72) Inventors:
  • WAGENER, Christoph
    22763 Hamburg (DE)
  • NOLLAU, Peter
    20146 Hamburg (DE)
  • NIENDORF, Axel
    22767 Hamburg (DE)

(74) Representative: Uexküll & Stolberg 
Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstraße 4
22607 Hamburg
22607 Hamburg (DE)


(56) References cited: : 
WO-A2-2008/007960
   
  • SUZUKI N. ET AL.: "Molecular cloning and expression of cDNA encoding human macrophage C-type lectin: Its unique carbohydrate binding specificity for Tn antigen", J. IMMUNOL., vol. 156, no. 1, 1 January 1996 (1996-01-01), pages 128-135, XP002046614,
  • WAGENER C. ET AL.: "Posttranslational modifications in tumor diagnosis", CLIN. CHEM. LAB. MED., vol. 46, no. Suppl. 1, May 2011 (2011-05), page S9, XP009164779,
  • NOLLAU P. ET AL.: "Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissues", J. HISTOCHEM. CYTOCHEM., vol. 61, no. 3, March 2013 (2013-03), pages 199-205, XP9171781,
  • MORTEZAI N. ET AL.: "Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL)", GLYCOBIOLOGY, vol. 23, no. 7, July 2013 (2013-07), pages 844-852, XP55074447, [retrieved on 2013-03-18]
  • JOHANSSON M.E.V. ET AL.: "The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions", PROC. NAT. ACAD. SCI. USA, vol. 108, no. Suppl. 1, March 2011 (2011-03), pages 4659-4665,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).